|
Odyssey, a Palo Alto, Calif.-based AI lab focused on general-purpose world models, scored $310 million in Series B funding at a $1.45 billion valuation. Natural Capital led the round, which included participation from Amazon, AMD Ventures, GV, EQT and others.
Atom Computing, a Berkeley, Calif.-based developer of large-scale quantum computers, has raised a total of more than $300 million, including a $100 million Series C round from investors including Third Point Ventures and DCVC.
Dream, a Tel Aviv-headquartered startup building sovereign AI infrastructure for governments, secured a $260 million investment, bringing the company’s valuation up to $3 billion. Bicycle Capital and Group 11 co-led the round, which included additional support from Antler, Bain Capital Ventures and Tru Arrow Partners.
Twenty, an Arlington, Va.-based cyber warfare startup, raised $100 million in Series B funding at a $1 billion valuation. Accel led the investment, which included participation from Point72 Ventures and Caffeinated Capital.
Nura Bio, a South San Francisco, Calif.-based biopharmaceutical company currently conducting studies in patients with amyotrophic lateral sclerosis, completed a $73.8 million Series B round. The Column Group led the funding, which saw participation from Euclidean Capital, Samsara BioCapital and Sanofi Ventures.
Gradial, a Seattle-based startup building AI agents to automate enterprise marketing operations, nabbed $65 million in Series C funding at a $675 million post-money valuation. Insight Partners led the investment, which included participation from VMG Partners, Madrona and Pruven.
Conduct, a London-based AI operating system provider, picked up $60 million in Series A funding. Index Ventures and Iconiq co-led the round, which saw contributions from Creandum and others.
Verse, a San Francisco-based energy infrastructure platform for the AI economy, collected $54 million in Series B funding. Bessemer Venture Partners led the round, which included support from GV and others.
COUR Pharma, a startup developing immune tolerance therapies for autoimmune diseases, closed a $50 million Series B round. Led by Lumira Ventures and Roche Venture Fund, the funding included participation from Pfizer Ventures, Angelini Ventures and T1D Fund.
Convey, a San Francisco-headquartered AI workforce platform, snagged $38 in Series A funding. Andreessen Horowitz led the investment, with Partner Joe Schmidt joining the company’s board.
Andera, an internal audit automation platform, raised $37 million in Series A funding led by Lightspeed Venture Partners.
Pramaana Labs, a San Francisco-based startup building a verification layer for AI, was seeded with a $27 million investment led by Khosla Ventures.
|